CRISPR Therapeutics AG - Common Shares — Balance Sheet (NASDAQ:CRSP) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 1.83 B2.75 B2.24 B2.23 B2.24 B2.27 B Total liabilities 163.73 M352.42 M367.58 M346.77 M309.95 M343.43 M Total equity 1.66 B2.4 B1.88 B1.88 B1.93 B1.92 B Total liabilities & shareholders' equities 1.83 B2.75 B2.24 B2.23 B2.24 B2.27 B Total debt —————— Net debt ——————

News

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

CRISPR Therapeutics AG (CRSP) Stock Dips While Market Gains: Key Facts

Prime Medicine Beats Beam Therapeutics In Patent Dispute - But Both Are Investable (PRME)

NTLA Surges 38% in a Month: Should You Buy, Sell or Hold the Stock?

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles

Crispr Therapeutics: Casgevy's Pediatric Win A Trigger For Bullish Sentiment

Vertex Gets FDA Nod for Expanded Use of Casgevy in SCD & TDT

Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech (VRTX)

Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know

CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors

Beam Therapeutics: A Better Entry Point Is Likely Coming (Rating Downgrade) (NASDAQ:BEAM)